AsiaPharm Investments Ltd. - Net Worth and Insider Trading

AsiaPharm Investments Ltd. Net Worth

The estimated net worth of AsiaPharm Investments Ltd. is at least $3.3 Billion dollars as of 2024-06-16. AsiaPharm Investments Ltd. is the of Shandong Boan Biotechnology Co Ltd and owns about 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) stock worth over $3.3 Billion. Details can be seen in AsiaPharm Investments Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that AsiaPharm Investments Ltd. has not made any transactions after 2024-04-12 and currently still holds the listed stock(s).

Transaction Summary of AsiaPharm Investments Ltd.

To

AsiaPharm Investments Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, AsiaPharm Investments Ltd. owns 1 companies in total, including Shandong Boan Biotechnology Co Ltd (HKSE:06955) .

Click here to see the complete history of AsiaPharm Investments Ltd.’s form 4 insider trades.

Insider Ownership Summary of AsiaPharm Investments Ltd.

Ticker Comapny Transaction Date Type of Owner
HKSE:06955 Shandong Boan Biotechnology Co Ltd 2024-04-12

AsiaPharm Investments Ltd. Latest Holdings Summary

AsiaPharm Investments Ltd. currently owns a total of 1 stock. AsiaPharm Investments Ltd. owns 360,596,456 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) as of April 12, 2024, with a value of $3.3 Billion.

Latest Holdings of AsiaPharm Investments Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:06955 Shandong Boan Biotechnology Co Ltd 2024-04-12 360,596,456 9.22 3,324,699,324

Holding Weightings of AsiaPharm Investments Ltd.


AsiaPharm Investments Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, AsiaPharm Investments Ltd. has made a total of 4 transactions in Shandong Boan Biotechnology Co Ltd (HKSE:06955) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shandong Boan Biotechnology Co Ltd is the sale of 0 shares on April 12, 2024, which brought AsiaPharm Investments Ltd. around $0.

Insider Trading History of AsiaPharm Investments Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

AsiaPharm Investments Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

AsiaPharm Investments Ltd. Ownership Network

Ownership Network List of AsiaPharm Investments Ltd.

No Data

Ownership Network Relation of AsiaPharm Investments Ltd.

Insider Network Chart

AsiaPharm Investments Ltd. Owned Company Details

What does Shandong Boan Biotechnology Co Ltd do?

Who are the key executives at Shandong Boan Biotechnology Co Ltd?

AsiaPharm Investments Ltd. is the of Shandong Boan Biotechnology Co Ltd. Other key executives at Shandong Boan Biotechnology Co Ltd include Ginkgo (PTC) Limited , Liu Dianbo , and Luye Life Sciences Group Ltd .

Shandong Boan Biotechnology Co Ltd (HKSE:06955) Insider Trades Summary

Over the past 18 months, AsiaPharm Investments Ltd. made no insider transaction in Shandong Boan Biotechnology Co Ltd (HKSE:06955). Other recent insider transactions involving Shandong Boan Biotechnology Co Ltd (HKSE:06955) include a net sale of 0 shares made by Liu Dianbo , a net sale of 0 shares made by yan tai lv ye yi yao kong gu ji tuan you xian gong si , and a net sale of 0 shares made by Luye Pharma Holdings Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shandong Boan Biotechnology Co Ltd (HKSE:06955) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Shandong Boan Biotechnology Co Ltd (HKSE:06955)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Shandong Boan Biotechnology Co Ltd Insider Transactions

No Available Data

AsiaPharm Investments Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for AsiaPharm Investments Ltd.. Currently GuruFocus does not have mailing address information for AsiaPharm Investments Ltd..

Discussions on AsiaPharm Investments Ltd.

No discussions yet.